Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endophthalmitis Vitrectomy Study (EVS)
NCT00000130Phase 3Completed
- Sponsor
- National Eye Institute
- Start
- Feb 1990
- Modality
- Reversible Covalent Inhibitors
01
Overview
Phase 3, randomised, open-label trial of ceftazidime and amikacin in endophthalmitis (4 arms), sponsored by National Eye Institute. Primary endpoint: Visual Acuity at 9 months. Started Feb 1990; status: completed.
02
Drugs
ceftazidimeamikacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT00000130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000130.